Insider Selling: ASP Isotopes (NASDAQ:ASPI) Director Sells $312,500.00 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Todd Wider sold 50,000 shares of the firm’s stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $6.25, for a total transaction of $312,500.00. Following the transaction, the director directly owned 722,247 shares of the company’s stock, valued at $4,514,043.75. The trade was a 6.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

ASP Isotopes Price Performance

Shares of ASP Isotopes stock opened at $5.63 on Friday. The firm has a market cap of $708.82 million, a P/E ratio of -2.71 and a beta of 3.51. The firm’s 50-day simple moving average is $6.26 and its 200-day simple moving average is $5.90. ASP Isotopes Inc. has a twelve month low of $3.92 and a twelve month high of $14.49. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.37 and a current ratio of 4.39.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.06. The firm had revenue of $8.36 million during the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

Hedge Funds Weigh In On ASP Isotopes

Several institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP acquired a new position in ASP Isotopes in the third quarter valued at about $34,000. BNP Paribas Financial Markets grew its stake in ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares during the last quarter. State of Wyoming acquired a new stake in shares of ASP Isotopes during the first quarter worth approximately $29,000. Legal & General Group Plc increased its holdings in shares of ASP Isotopes by 30.4% during the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after buying an additional 1,953 shares in the last quarter. Finally, IFP Advisors Inc bought a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $48,000. 16.80% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.